October 18 (SeeNews) - Macedonian drug maker Alkaloid [MSE:ALK] expects its revenues to rise by 8% in 2017, from 8.3 billion denars ($158.8 million/135 million euro) last year, Zhivko Mukaetov, CEO and president of the company, has told SeeNews.